Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $868.0 million.

  • Alignment Healthcare's Cost of Revenue rose 4149.98% to $868.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 4416.01%. This contributed to the annual value of $2.4 billion for FY2024, which is 4833.42% up from last year.
  • Latest data reveals that Alignment Healthcare reported Cost of Revenue of $868.0 million as of Q3 2025, which was up 4149.98% from $881.7 million recorded in Q2 2025.
  • Over the past 5 years, Alignment Healthcare's Cost of Revenue peaked at $881.7 million during Q2 2025, and registered a low of $251.1 million during Q1 2021.
  • For the 5-year period, Alignment Healthcare's Cost of Revenue averaged around $467.8 million, with its median value being $397.9 million (2023).
  • Per our database at Business Quant, Alignment Healthcare's Cost of Revenue surged by 1198.46% in 2022 and then soared by 5417.85% in 2024.
  • Quarter analysis of 5 years shows Alignment Healthcare's Cost of Revenue stood at $259.6 million in 2021, then rose by 25.59% to $326.0 million in 2022, then grew by 28.15% to $417.8 million in 2023, then soared by 47.19% to $614.9 million in 2024, then soared by 41.17% to $868.0 million in 2025.
  • Its last three reported values are $868.0 million in Q3 2025, $881.7 million for Q2 2025, and $820.9 million during Q1 2025.